Johnson & Johnson's chief scientific officer said it's unlikely the coronavirus will be eradicated without a vaccine. Dr. Paul Stoffels, appearing on ABC's 'This Week' Sunday, responded to comments from President Donald Trump last week that, 'With or without a vaccine, it&
Johnson & Johnson's chief scientific officer said it's unlikely the coronavirus will be eradicated without a vaccine.
Dr. Paul Stoffels, Johnson & Johnson chief scientific officer, says COVID-19 is spreading"so fast" around the world and it won't pass without a vaccine. "We need these sort of efforts at J&J -- and others are doing them," Dr. George Yancopoulos, president and chief scientific officer at biotechnology firm Regeneron, said in a joint interview with Stoffels."We need the sort of efforts that we're doing that can provide these immediate sources of both prevention and treatment that can have an impact until we get a vaccine.
"Vaccines can provide permanent immunity to much larger numbers of people. This is why we need all of these efforts," he said. When pressed by Stephanopoulos on whether the expedited pace of treatment development was still safe for consumers, Yancopoulos said,"I think the most important thing -- you already heard from Dr. Stoffels -- is that we have a strong and powerful set of technologies throughout the ecosystem in basic research and in industry that allows us to fight these battles when they appear."
Although he expects his company to produce a vaccine by the end of the year, Stoffels said whether it could be available for consumption would be a decision for the government."Clinical trials will need to be done to show that it's effective and that will take some time.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Drug treatment a stopgap for vaccine to eradicate COVID-19: Chief scientific officerIt's unlikely the coronavirus will be eradicated without a vaccine, Johnson & Johnson's chief scientific officer told ABC News in response to comments made by the president last week.
Lire la suite »
Study shows Covid-19 patients who took heartburn drug were less likely to die, but researchers caution more research is neededPatients who took a common heartburn medicine while hospitalized for Covid-19 were more than twice as likely to survive the infection, according to a paper posted Friday on a pre-publication website. But it's unclear whether the patients fared better because of the famotidine or if it was a coincidence.
Lire la suite »
Drug treatment only a stopgap for vaccine that could eradicate the coronavirus: Johnson & Johnson's chief scientific officerDr. Paul Stoffels, Johnson & Johnson chief scientific officer, says COVID-19 is spreading 'so fast' around the world and it won’t pass without a vaccine. Clinical trials begin in September with “the aim to deliver 1 billion vaccines next year,' he adds.
Lire la suite »
Projection estimates 135,000 US deaths by August; testing expanded for Fujifilm flu drug“I hope you wear these uncommon circumstances as a badge of honor.” Apple CEO Tim Cook delivered Ohio State's virtual 2020 commencement address. Here’s his advice for new grads.
Lire la suite »
Schumer calls on VA to explain use of unproven drug on vetsSen. Chuck Schumer called on the Department of Veterans Affairs to explain why it allowed the use of an unproven drug on veterans for the coronavirus
Lire la suite »
Schumer calls on VA to explain use of unproven drug on vetsSen. Chuck Schumer wants the Department of Veterans Affairs to explain why it allowed the use of hydroxychloroquine on veterans to treat coronavirus. President Trump has heavily promoted the malaria drug for COVID-19 despite a lack of scientific evidence.
Lire la suite »